Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun 6:6:69.
doi: 10.4103/2277-9175.190994. eCollection 2017.

Central Beneficial Effects of Trimetazidine on Psychomotor Performance in Normal Healthy Volunteers

Hayder M Al-Kuraishy  1 , Ali I Al-Gareeb  1
Affiliations

Central Beneficial Effects of Trimetazidine on Psychomotor Performance in Normal Healthy Volunteers

Hayder M Al-Kuraishy et al. Adv Biomed Res. .

Abstract

Background: Trimetazidine is a fatty oxidation inhibitor, leading to shifting of energy substrate from fatty acid oxidation toward glucose oxidation that leads to the reduction of oxygen requirement. The aims of the present study were to elucidate the effects of trimetazidine on psychomotor performance and vigilance on normal healthy volunteers.

Materials and methods: A total of 234 subjects (age 22-25 years) were recruited in this study. The volunteers were randomizing into two groups with 117 volunteers in each group. Group I received an inert starch capsule served as a control, and Group II received trimetazidine tablet 15 mg/day. The duration of therapy was 5 days. Test procedure was done at 9.00 a.m. on the psychomotor tester. Before the drug administration, prescore values were recorded and then after 5 days of therapy, the postscore values were recorded.

Results: The placebo did not demonstrate a significant effect on all psychomotor performances and flicker-fusion elements (P > 0.05). Trimetazidine therapy produced a highly significant effect on all components of psychomotor performances and flicker-fusion parameters (P < 0.001) compared with pretreatment era.

Conclusion: We conclude that trimetazidine improves psychomotor performance and vigilance in normal healthy volunteers through advancing total reaction time and critical flicker-fusion frequency.

Keywords: Critical flicker-fusion frequency; psychomotor performance; trimetazidine.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Sandhiya S, Dkhar SA, Pillai AA, George M, Jayaraman B, Chandrasekaran A. Comparison of ranolazine and trimetazidine on glycemic status in diabetic patients with coronary artery disease – A randomized controlled trial. J Clin Diagn Res. 2015;9:OC01–5. - PMC - PubMed
    1. Peng S, Zhao M, Wan J, Fang Q, Fang D, Li K. The efficacy of trimetazidine on stable angina pectoris: A meta-analysis of randomized clinical trials. Int J Cardiol. 2014;177:780–5. - PubMed
    1. Zhang F, Huang B, Zhao Y, Tang S, Xu H, Wang L, et al. BNC Protects H9c2 Cardiomyoblasts from H 2 O 2 -Induced Oxidative Injury through ERK1/2 signaling pathway. Evid Based Complement Alternat Med 2013. 2013 802784. - PMC - PubMed
    1. Iqbal S, Baziany A, Hussain M, James S, Wright S, Hemmings S, et al. Trimetazidine as a potential neuroprotectant in transient global ischemia in gerbils: A behavioral and histological study. Brain Res. 2002;928:1–7. - PubMed
    1. Hassanzadeh G, Hosseini A, Pasbakhsh P, Akbari M, Ghaffarpour M, Takzare N, et al. Trimetazidine prevents oxidative changes induced in a rat model of sporadic type of Alzheimer's disease. Acta Med Iran. 2015;53:17–24. - PubMed